全文获取类型
收费全文 | 3893篇 |
免费 | 184篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 88篇 |
妇产科学 | 92篇 |
基础医学 | 458篇 |
口腔科学 | 61篇 |
临床医学 | 220篇 |
内科学 | 999篇 |
皮肤病学 | 60篇 |
神经病学 | 297篇 |
特种医学 | 131篇 |
外科学 | 584篇 |
综合类 | 18篇 |
预防医学 | 112篇 |
眼科学 | 35篇 |
药学 | 280篇 |
中国医学 | 2篇 |
肿瘤学 | 602篇 |
出版年
2023年 | 14篇 |
2022年 | 24篇 |
2021年 | 78篇 |
2020年 | 50篇 |
2019年 | 49篇 |
2018年 | 48篇 |
2017年 | 71篇 |
2016年 | 76篇 |
2015年 | 79篇 |
2014年 | 94篇 |
2013年 | 106篇 |
2012年 | 190篇 |
2011年 | 222篇 |
2010年 | 106篇 |
2009年 | 119篇 |
2008年 | 194篇 |
2007年 | 181篇 |
2006年 | 206篇 |
2005年 | 196篇 |
2004年 | 218篇 |
2003年 | 193篇 |
2002年 | 189篇 |
2001年 | 151篇 |
2000年 | 139篇 |
1999年 | 144篇 |
1998年 | 33篇 |
1997年 | 49篇 |
1996年 | 34篇 |
1995年 | 32篇 |
1994年 | 26篇 |
1993年 | 27篇 |
1992年 | 76篇 |
1991年 | 54篇 |
1990年 | 74篇 |
1989年 | 74篇 |
1988年 | 78篇 |
1987年 | 57篇 |
1986年 | 50篇 |
1985年 | 51篇 |
1984年 | 30篇 |
1983年 | 41篇 |
1981年 | 15篇 |
1979年 | 26篇 |
1977年 | 9篇 |
1974年 | 13篇 |
1972年 | 12篇 |
1969年 | 12篇 |
1968年 | 10篇 |
1967年 | 9篇 |
1966年 | 8篇 |
排序方式: 共有4090条查询结果,搜索用时 328 毫秒
111.
Tetsuro Sohda Takayuki Hanano Hisanori Miyamoto Yoko Kitano Kaoru Iwata Masanori Yokoyama Makoto Irie Yasuaki Takeyama Satoshi Shakado Shotaro Sakisaka 《Hepatology International》2008,2(2):258-261
An 80-year-old man was admitted to our hospital because of the rupture of the liver. Laboratory data showed iron-deficiency
anemia, although there was no liver dysfunction. A computed tomography scan showed large liver tumor with intraperitoneal
hemorrhage, and since a serum level of α-fetoprotein (AFP) was extremely high, we initially suspected a rupture of hepatocellular
carcinoma (HCC). Transarterial embolization was performed to stop bleeding from the tumor, followed by an endoscopic examination
that revealed advanced gastric cancer. Histological analysis revealed that both the gastric and the hepatic tumors were moderately
to poorly differentiated adenocarcinoma, as well as that both tumors were immunohistochemically positive for AFP. Finally,
we diagnosed AFP-producing gastric cancer associated with liver metastasis. Rupture of metastatic liver cancer is rare, and
accordingly, distinction from HCC is important, particularly for the cases of AFP-producing gastric cancer. 相似文献
112.
113.
Masahiko Nakayama Hisanori Kobayashi Koji Fukushima Miwako Ishido Yuji Komada Kazutake Yoshizawa 《Hepatology International》2016,10(1):158-168
Background
Simeprevir with peginterferon and ribavirin has been used for the treatment of chronic hepatitis caused by genotype 1 hepatitis C virus (HCV). We explored the predictive factors for sustained virological response (SVR) and viral relapse using datasets from four Japanese phase 3 studies (CONCERTO).Methods
We used a multiple logistic regression model. First, an integrated dataset comprising 357 patients was analyzed. Subsequently, prior treatment-naïve and relapser (223 patients) and nonresponder (134 patients) of interferon-based treatment subsets were analyzed to identify predictors of SVR. A subset of nonresponders (106 patients) who were treated ≥24 weeks was also analyzed to identify predictors for viral relapse.Results
In the integrated dataset, prior treatment response was significantly associated with SVR. In subset analyses, interleukin-28B (IL28B) TT genotype and undetectable plasma HCV RNA level at week 4 were associated in treatment-naïve patients and relapsers [odds ratio (OR); 4.106 and 3.701, respectively]. In the nonresponders, the IL28B TT genotype population was very small, and inosine triphosphatase (ITPA) and undetectable plasma HCV RNA at week 4 were associated (OR; 2.506 and 3.333, respectively). Furthermore, ribavirin dose intensity (RBV-DI) and detectable plasma HCV RNA at week 4 were significantly associated with viral relapse (OR; 0.327 and 2.922, respectively).Conclusion
IL28B and plasma HCV RNA level at week 4 were clinically relevant predictive factors for SVR in treatment-naïve patients and relapsers. Moreover, RBV-DI and plasma HCV level at week 4 were identified as relevant predictive factors for viral relapse in nonresponders.114.
115.
Y Fujimura Y Usami K Titani K Niinomi K Nishio T Takase A Yoshioka H Fukui 《Blood》1991,77(1):113-120
Anti-von Willebrand factor (vWF) monoclonal antibody NMC-4 completely inhibited vWF binding to platelet glycoprotein (GP) lb induced by either ristocetin or botrocetin at an IgG concentration of approximately 10 micrograms/mL, and also blocked binding of asialo-vWF to GP lb. NMC-4 coupled beads isolated a 97-Kd fragment (Fr) from a whole tryptic digest of vWF. The N-terminal sequencing of the nonreduced 97-Kd Fr, in combination with amino acid analysis, showed it to be a homodimer of residues 449 through 728 of the constituent subunit. Present data, together with the results obtained from previous studies, confirm the existence of one or three possible inter-subunit disulfide bonds between cysteine residues 459, 462, and 464. NMC-4 bound to reduced vWF Fr(s) more weakly than to nonreduced Fr(s), but it did not react with Fr III-T2 of vWF, a disulfide-linked twin heterodimer of residues 273 through 511 and 674 through 728 (Marti et al, Biochemistry 26:8099, 1987). Fr III-T2 completely inhibited ristocetin-induced vWF binding at a concentration of 100 mumol/L but had no effect on botrocetin-induced binding. In addition, both the N- and C-terminal polypeptides, residues 449 through 549 and 674 through 728, generated by subdigestion of the 52/48-Kd Fr (Fujimura et al, J Biol Chem 261:381, 1986), inhibited preferentially ristocetin-induced vWF binding without affecting to botrocetin-induced vWF binding. These findings suggest that amino acid residues 512 through 673 of the vWF subunit are involved in botrocetin-induced vWF binding. 相似文献
116.
Insulin production in a neuroectodermal tumor that expresses islet factor-1, but not pancreatic-duodenal homeobox 1 总被引:4,自引:0,他引:4
117.
BACKGROUND: Recent studies have shown that tamoxifen, which belongs to a group called selective estrogen receptor modulators (SERM), may exert protective effects against cardiovascular diseases and stroke in postmenopausal women. On the other hand, abnormalities in physical properties of the cell membranes may underlie the defects that are strongly linked to hypertension, stroke, and other cardiovascular diseases. The present study was performed to investigate the effects of tamoxifen on cell membrane fluidity (a reciprocal value of membrane microviscosity) in normotensive and hypertensive postmenopausal women. METHODS AND RESULTS: We used an electron paramagnetic resonance (EPR) and spin-labeling method. Tamoxifen significantly decreased the order parameter (S) for 5-nitroxide stearate (5-NS) and the peak height ratio (h(o)/h(-1)) for 16-NS obtained from EPR spectra of erythrocyte membranes in normotensive postmenopausal women (mean +/- SEM, order parameter value; control 0.719 +/- 0.002, n = 41; tamoxifen 1 x 10(-7) mol/L 0.704 +/- 0.002, n = 41, P < .0001; tamoxifen 1 x 10(-6) mol/L 0.696 +/- 0.002, n = 41, P < .0001; tamoxifen 1 x 10(-5) mol/L 0.692 +/- 0.002, n = 41, P < .0001). The finding indicated that tamoxifen increased the membrane fluidity and improved the membrane microviscosity of erythrocytes. The membrane action of tamoxifen was antagonized by the estrogen receptor antagonist ICI 182,780. The effect of tamoxifen was significantly potentiated by the nitric oxide (NO) donors, l-arginine and S-nitroso-N-acetylpenicillamine, and a cGMP analog 8-bromo-cGMP. In contrast, the change evoked by tamoxifen was counteracted by the NO synthase inhibitors N(G)-nitro-l-arginine-methyl-ester and asymmetric dimethyl-l-arginine. In hypertensive postmenopausal women, the membrane fluidity of erythrocytes was significantly lower than in normotensive postmenopausal women. The effect of tamoxifen on the membrane fluidity was more pronounced in hypertensive postmenopausal women than in normotensive postmenopausal women. CONCLUSIONS: These results showed that tamoxifen increased the membrane fluidity of erythrocytes and improved the rigidity of cell membranes in postmenopausal women, to some extent, through the NO- and cGMP-dependent mechanisms. Furthermore, the greater effect of tamoxifen in hypertensive postmenopausal women suggests that tamoxifen could have a beneficial effect in regulating the blood rheologic behavior and in the improvement of the microcirculation in hypertension. 相似文献
118.
Giovanna Leoni Philipp-Alexander Neumann Nazila Kamaly Miguel Quiros Hikaru Nishio Hefin R. Jones Ronen Sumagin Roland S. Hilgarth Ashfaqul Alam Gabrielle Fredman Ioannis Argyris Emile Rijcken Dennis Kusters Chris Reutelingsperger Mauro Perretti Charles A. Parkos Omid C. Farokhzad Andrew S. Neish Asma Nusrat 《The Journal of clinical investigation》2015,125(3):1215-1227
Epithelial restitution is an essential process that is required to repair barrier function at mucosal surfaces following injury. Prolonged breaches in epithelial barrier function result in inflammation and further damage; therefore, a better understanding of the epithelial restitution process has potential for improving the development of therapeutics. In this work, we demonstrate that endogenous annexin A1 (ANXA1) is released as a component of extracellular vesicles (EVs) derived from intestinal epithelial cells, and these ANXA1-containing EVs activate wound repair circuits. Compared with healthy controls, patients with active inflammatory bowel disease had elevated levels of secreted ANXA1-containing EVs in sera, indicating that ANXA1-containing EVs are systemically distributed in response to the inflammatory process and could potentially serve as a biomarker of intestinal mucosal inflammation. Local intestinal delivery of an exogenous ANXA1 mimetic peptide (Ac2-26) encapsulated within targeted polymeric nanoparticles (Ac2-26 Col IV NPs) accelerated healing of murine colonic wounds after biopsy-induced injury. Moreover, one-time systemic administration of Ac2-26 Col IV NPs accelerated recovery following experimentally induced colitis. Together, our results suggest that local delivery of proresolving peptides encapsulated within nanoparticles may represent a potential therapeutic strategy for clinical situations characterized by chronic mucosal injury, such as is seen in patients with IBD. 相似文献
119.
Junya Yamamoto Daigo Nakazawa Saori Nishio Yasunobu Ishikawa Minoru Makita Yoshihiro Kusunoki So Nagai Yuichiro Fujieda Masahiko Takahata Kanji Yamada Tsuyoshi Yamamura Akihiko Yotsukura Masanobu Saito Masaru Shimazaki Tatsuya Atsumi 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2020,24(2):146-153
Adynamic bone disease in HD patients is characterized by skeletal resistance to parathyroid hormone (PTH) or suppression of PTH release, leading to a downregulated bone turnover and bone fracture. Hence, we examined the efficacy of weekly teriparatide for HD patients with low PTH indicating adynamic bone disease without a history of parathyroidectomy. Fifteen HD patients with low PTH were recruited in this prospective observational study. Of them, 10 received teriparatide for 12 months and five nontreated patients were enrolled as control. Primary outcomes were defined as the changes in bone mineral density and bone turnover markers. Bone mineral density at the lumbar spine increased by 3.7% and 2.5% at 6 and 12 months, respectively, and bone formation markers increased, while bone resorption markers did not change in the teriparatide group. At 12 months after teriparatide administration, endogenous PTH was secreted followed by the recovery of low bone turnover. 40% of patients in the teriparatide group dropped out due to adverse events and the most common adverse event was transient hypotension. This study suggests that weekly teriparatide for HD patients with low PTH in the absence of parathyroidectomy accelerates bone formation and bone turnover, leading to increased trabecular bone mass and secretion of endogenous PTH. 相似文献
120.
Yoshito Tomimaru Nariaki Fukuchi Shigekazu Yokoyama Takuji Mori Masahiro Tanemura Kenji Sakai Yutaka Takeda Masanori Tsujie Terumasa Yamada Atsushi Miyamoto Yasuji Hashimoto Hisanori Hatano Junzo Shimizu Keishi Sugimoto Masaki Kashiwazaki Shogo Kobayashi Yuichiro Doki Hidetoshi Eguchi 《Journal of hepato-biliary-pancreatic sciences》2020,27(8):451-460